Cited by 226Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatmentsParkinson's Disease Mechanisms and Treatments

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index; 45 of the 54 sources its claims cite were checked for support.

Crosstalk between astrocytes and microglia results in increased degradation of α-synuclein and amyloid-β aggregates

Open access

Abstract

Background: Alzheimer’s disease (AD) and Parkinson’s disease (PD) are characterized by brain accumulation of aggregated amyloid-beta (Aβ) and alpha-synuclein (αSYN), respectively. In order to develop effective therapies, it is crucial to understand how the Aβ/αSYN aggregates can be cleared. Compelling data indicate that neuroinflammatory cells, including astrocytes and microglia, play a central role in the pathogenesis of AD and PD. However, how the interplay between the two cell types affects their clearing capacity and consequently the disease progression remains unclear. Methods: The aim of the present study was to investigate in which way glial crosstalk influences αSYN and Aβ pathology, focusing on accumulation and degradation. For this purpose, human-induced pluripotent cell (hiPSC)-derived astrocytes and microglia were exposed to sonicated fibrils of αSYN or Aβ and analyzed over time. The capacity of the two cell types to clear extracellular and intracellular protein aggregates when either cultured separately or in co-culture was studied using immunocytochemistry and ELISA. Moreover, the capacity of cells to interact with and process protein aggregates was tracked using time-lapse microscopy and a customized “close-culture” chamber, in which the apical surfaces of astrocyte and microglia monocultures were separated by a <1 mm space. Results: Our data show that intracellular deposits of αSYN and Aβ are significantly reduced in co-cultures of astrocytes and microglia, compared to monocultures of either cell type. Analysis of conditioned medium and imaging data from the “close-culture” chamber experiments indicate that astrocytes secrete a high proportion of their internalized protein aggregates, while microglia do not. Moreover, co-cultured astrocytes and microglia are in constant contact with each other via tunneling nanotubes and other membrane structures. Notably, our live cell imaging data demonstrate that microglia, when attached to the cell membrane of an astrocyte, can attract and clear intracellular protein deposits from the astrocyte. Conclusions: Taken together, our data demonstrate the importance of astrocyte and microglia interactions in Aβ/αSYN clearance, highlighting the relevance of glial cellular crosstalk in the progression of AD- and PD-related brain pathology.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

Human iPSC-derived astrocytes and microglia were exposed to α-synuclein or amyloid-β fibrils in monoculture and co-culture to study glial crosstalk in aggregate clearance. Co-culture reduced intracellular αSYN and Aβ deposits, with astrocytes transferring aggregates to microglia via secretion and direct contact, including tunneling nanotubes.

Key findings

  • In monocultures, astrocytes accumulated αSYN over 7 days, whereas microglia showed no increase from 24 h to 7 days and more effectively reduced intracellular αSYN after pulse-chase; some deposits remained in both monocultures at 24 h + 6 days.
  • In co-cultures, total intracellular αSYN was significantly reduced at day 7 versus 24 h, due to decreases in both microglia and astrocytes; astrocytic αSYN reduction was opposite to the accumulation seen in pure astrocyte cultures.
  • For Aβ, co-culture reduced total intracellular Aβ at day 7 versus 24 h in both cell types, including a reduction in astrocytes that was not observed in astrocytic monocultures.
  • ELISA showed that after 24 h, almost 75% of added αSYN was cleared from medium in all cultures; microglia cleared extracellular Aβ more effectively after 24 h, while astrocytes showed no significant Aβ uptake from 24 h to 7 days and had higher Aβ levels at 4 days + 3 days, suggesting greater secretion.
  • Conditioned-media and close-culture chamber experiments showed astrocytes transfer a large proportion of internalized αSYN to microglia via secretory mechanisms, while microglia hardly transfer αSYN to astrocytes; TNTs and membrane contacts were observed, and live imaging showed microglia attracting and clearing intracellular αSYN deposits from astrocytes.

Methods

  • Human iPSC-derived astrocytes and microglia were generated from the same Cntrl9 cell line and exposed to sonicated Cy3-labelled αSYN fibrils (0.5 μM) or Aβ fibrils (0.2 μM) for 24 h, 4 days, or 7 days, or given pulse-chase treatment, in monocultures and co-cultures.
  • Analyses included immunocytochemistry, ELISA for total αSYN and Aβ in medium, cytokine array, time-lapse microscopy, and a customized “close-culture” chamber separating apical surfaces of astrocyte and microglia monocultures by <1 mm.
  • Image analysis measured integrated density of αSYN/Aβ within Iba1- or vimentin-outlined cells; 60 Z-stack images per time point/treatment from three independent experiments were analyzed with Kruskal-Wallis/Dunn’s correction, and ELISA medium samples from four experiments were analyzed with one-way ANOVA/Tukey correction.

Limitations

  • The paper states that further studies, for example using multi-photon microscopy, are needed to confirm the observed astrocyte–microglia transfer and clearance phenomenon in the living brain.
  • Evident from the text: all experiments are in vitro with hiPSC-derived glia, with no in vivo AD/PD model or human brain tissue validation.
  • Evident from the text: direct comparison of Cy3 intensity between Aβ and αSYN could not be done because labelling efficiency may differ, and the cytokine array showed very little effect of aggregated αSYN or Aβ on the cytokine profile.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s12974-021-02158-3

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

45 of 54 cited sources checked · 12 supported · 0 flagged · accuracy not yet measured

  • Premisecitation

    Cultured astrocytes accumulate αSYN and Aβ aggregates but not the monomeric form of the proteins.

    “We have previously reported that cultured astrocytes accumulate αSYN and Aβ aggregates but not the monomeric form of the proteins [11, 12].”
    Quote in the paperSubstantial claim2 of 2 sources checked
    • cites [11] Rostami J, Holmqvist S, Lindström V, Sigvardson J, Westermark GT, Ingelsson M, et al. Human astrocytes transfer aggregated alpha-synuclein via tunneling nanotubes. J Neurosci. 2017;37(49):11835–53. https://doi.org/10.1523/JNEUROSCI.0983-17.2017. source
    • cites [12] Söllvander S, Nikitidou E, Brolin R, Söderberg L, Sehlin D, Lannfelt L, et al. Accumulation of amyloid-β by astrocytes result in enlarged endosomes and microvesicle-induced apoptosis of neurons. Molecular Neurodegeneration. 2016;11(1):38. https://doi.org/10.1186/s13024-016-0098-z. source
  • Premisecitation

    The αSYN and Aβ accumulation result in severe cellular stress, indicated by lysosomal and mitochondrial deficiencies.

    “The αSYN and Aβ accumulation result in severe cellular stress, indicated by lysosomal and mitochondrial deficiencies [11, 12, 23].”
    Quote in the paperSubstantial claim2 of 3 sources checked
    • cites [11] Rostami J, Holmqvist S, Lindström V, Sigvardson J, Westermark GT, Ingelsson M, et al. Human astrocytes transfer aggregated alpha-synuclein via tunneling nanotubes. J Neurosci. 2017;37(49):11835–53. https://doi.org/10.1523/JNEUROSCI.0983-17.2017. source

      The Results section reports mitochondrial defects after α-SYN oligomer exposure in human astrocytes, and the Discussion says α-SYN accumulation disrupts lysosomal machinery and is stressful to the cells. The cited paper does not establish the same effects for Aβ accumulation. Page numbers are not available in our copy. (LLM, conf=0.89)

      Experimental — accuracy not yet measured
    • cites [12] Söllvander S, Nikitidou E, Brolin R, Söderberg L, Sehlin D, Lannfelt L, et al. Accumulation of amyloid-β by astrocytes result in enlarged endosomes and microvesicle-induced apoptosis of neurons. Molecular Neurodegeneration. 2016;11(1):38. https://doi.org/10.1186/s13024-016-0098-z. source

      The Background and Conclusion (pages unavailable in our copy) state that intracellular Aβ accumulation in astrocytes causes severe endosomal and lysosomal defects. The paper does not establish the sentence’s claims about αSYN accumulation or mitochondrial deficiencies. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
    • cites [23] Lindström V, Gustafsson G, Sanders LH, Howlett EH, Sigvardson J, Kasrayan A, et al. Extensive uptake of α-synuclein oligomers in astrocytes results in sustained intracellular deposits and mitochondrial damage. Mol Cell Neurosci. 2017;82:143–56. https://doi.org/10.1016/j.mcn.2017.04.009. source
  • Premisecitation

    Astrocytes are capable of stimulating microglia phagocytosis by secretion of cytokines such as IL33 and the complement protein C3.

    “Several studies have demonstrated that astrocytes are capable of stimulating microglia phagocytosis by secretion of cytokines such as IL33 and the complement protein C3 [19, 34].”
    Quote in the paperNot a substantial claim2 of 2 sources checked
    • cites [19] Batlle M, Ferri L, Andrade C, Ortega F-J, Vidal-Taboada JM, Pugliese M, et al. Astroglia-microglia cross talk during neurodegeneration in the rat hippocampus. Biomed Res Int. 2015;2015:102419. source

      The Introduction says astrocytes release S100B, which modulates microglial activity, and the Discussion describes a change in microglial phagocytic morphology after astrocyte depletion. Neither passage says astrocyte-secreted factors stimulate microglial phagocytosis, and the searched passages do not identify IL33 or C3 as mediators. Page numbers were not available in our copy. (LLM, conf=0.83)

      Experimental — accuracy not yet measured
    • cites [34] Park J, Wetzel I, Marriott I, Dréau D, D’Avanzo C, Kim DY, et al. A 3D human triculture system modeling neurodegeneration and neuroinflammation in Alzheimer’s disease. Nat Neurosci. 2018;21(7):941–51. https://doi.org/10.1038/s41593-018-0175-4. source

      The Discussion reports that the neuron–astrocyte culture secreted chemokines, including CCL2/MCP-1, that contributed to microglial recruitment. It does not say that astrocytes stimulated microglial phagocytosis through IL-33 or C3; its separate discussion of complement concerns C1q and synapse engulfment in mouse models. (LLM, conf=0.82)

      Experimental — accuracy not yet measured
  • Premisecitation

    Damisah et al. found that microglia eliminated from mice using a CSF1R antagonist, after which neuronal cell death was induced, resulted in astrocytes engulfing material intended for microglia but degrading it at a slower rate.

    “Damisah et al. provide support for this in their recent study, where microglia were eliminated from mice using a CSF1R antagonists, after which neuronal cell death was induced. They found that astrocytes engulfed the material which was intended for microglia but degraded it at a slower rate [10].”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [10] Damisah EC, Hill RA, Rai A, Chen F, Rothlin CV, Ghosh S, et al. Astrocytes and microglia play orchestrated roles and respect phagocytic territories during neuronal corpse removal in vivo. Sci Adv. 2020;6:eaba3239. source

      The Results section, “A multicellular astrocytic reaction is responsible for cell body removal in the absence of microglia” (page unavailable), confirms CSF1R-antagonist treatment, induced neuronal apoptosis, astrocytic compensation, and slower cell-body removal. It does not establish a slower rate of degradation specifically; the authors also speculate that astrocytes digest cell bodies piecemeal rather than fully engulfing them. (LLM, conf=0.87)

      Experimental — accuracy not yet measured
  • Premisecitation

    Astrocytes, but not microglia, have the capacity to act as antigen-presenting cells when exposed to αSYN fibrils.

    “In a recent publication, we showed that astrocytes, but not microglia, have the capacity to act as antigen-presenting cells (APCs) when exposed to αSYN fibrils [24].”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [24] Rostami J, Fotaki G, Sirois J, Mzezewa R, Bergström J, Essand M, et al. Astrocytes have the capacity to act as antigen-presenting cells in the Parkinson’s disease brain. Journal of Neuroinflammation. 2020;17(1):119. https://doi.org/10.1186/s12974-020-01776-7. source
  • Probably not a substantial claim. 15
  • It may state two separate claims as one. 29
  • Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.

    Premisecitation

    The conversation between microglia and astrocytes starts already during early development and remains throughout life.

    “The conversation between microglia and astrocytes starts already during early development and remains throughout life [1].”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [1] Matejuk A, Ransohoff RM. Crosstalk between astrocytes and microglia: an overview. Frontiers in Immunology. 2020;11:1416. https://doi.org/10.3389/fimmu.2020.01416. source
  • Probably not a substantial claim. It may state two separate claims as one.

    Premisecitation

    In the AD and PD brain, both astrocytes and microglia acquire reactive, inflammatory phenotypes and can effectively phagocytose aggregated proteins and cell debris, as well as secrete various cytokines and inflammatory mediators.

    “In the AD and PD brain, both astrocytes and microglia acquire reactive, inflammatory phenotypes and can effectively phagocytose aggregated proteins and cell debris, as well as secrete various cytokines and inflammatory mediators [8–13].”
    Quote in the paperSubstantial claim5 of 6 sources checked
    • cites [8] Peri F, Nüsslein-Volhard C. Live imaging of neuronal degradation by microglia reveals a role for v0-ATPase a1 in phagosomal fusion in vivo. Cell. 2008;133(5):916–27. https://doi.org/10.1016/j.cell.2008.04.037. source

      The Introduction and the section on in vivo imaging of zebrafish embryos support that microglia engulf and digest apoptotic neurons. The paper does not establish the claim for AD or PD brains, or show that astrocytes and microglia phagocytose aggregated proteins or secrete cytokines and inflammatory mediators in those conditions. (LLM, conf=0.87)

      Experimental — accuracy not yet measured
    • cites [9] Sofroniew MV. Multiple roles for astrocytes as effectors of cytokines and inflammatory mediators. The Neuroscientist: A Review Journal Bringing Neurobiology, Neurology and Psychiatry. 2014;20(2):160–72. https://doi.org/10.1177/1073858413504466. source
    • cites [10] Damisah EC, Hill RA, Rai A, Chen F, Rothlin CV, Ghosh S, et al. Astrocytes and microglia play orchestrated roles and respect phagocytic territories during neuronal corpse removal in vivo. Sci Adv. 2020;6:eaba3239. source

      The Introduction and Discussion report that astrocytes and microglia remove dying neurons and cellular debris, supporting the debris-phagocytosis part of the claim. The paper does not establish this in AD or PD brains, or show that both cell types phagocytose aggregated proteins, acquire inflammatory phenotypes, or secrete cytokines and inflammatory mediators. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
    • cites [11] Rostami J, Holmqvist S, Lindström V, Sigvardson J, Westermark GT, Ingelsson M, et al. Human astrocytes transfer aggregated alpha-synuclein via tunneling nanotubes. J Neurosci. 2017;37(49):11835–53. https://doi.org/10.1523/JNEUROSCI.0983-17.2017. source

      The Introduction (page not provided) says reactive astrocytes engulf dead cells and aggregates of amyloid β and α-synuclein, and that astrocytes can produce cytokines and chemokines. The paper does not establish the corresponding inflammatory, phagocytic, and secretory claims for microglia in both AD and PD brains. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
    • cites [12] Söllvander S, Nikitidou E, Brolin R, Söderberg L, Sehlin D, Lannfelt L, et al. Accumulation of amyloid-β by astrocytes result in enlarged endosomes and microvesicle-induced apoptosis of neurons. Molecular Neurodegeneration. 2016;11(1):38. https://doi.org/10.1186/s13024-016-0098-z. source

      The Background (page unavailable) describes reactive astrocytes and microglia around amyloid plaques in AD, says both secrete cytokines, and reports that astrocytes engulf dead cells and protein aggregates. It does not establish the same combined account for both cell types in PD brains; the Discussion also cautions that astrocytes degrade ingested aggregates slowly. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
    • cites [13] Marín-Teva JL, Dusart I, Colin C, Gervais A, van Rooijen N, Mallat M. Microglia promote the death of developing Purkinje cells. Neuron. 2004;41(4):535–47. https://doi.org/10.1016/S0896-6273(04)00069-8. source

      The passage on phagocytic behavior in cerebellar slices reports microglia engulfing dying Purkinje cells and says astroglial cells can occasionally ingest apoptotic cell bodies (page unavailable). It does not establish reactive phenotypes, clearance of aggregated proteins, or cytokine secretion by both cell types in AD or PD brains; the Molecular Mediators section instead examines microglial effects during development. (LLM, conf=0.85)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim. The paper’s conclusions may not depend on it.

    Study design and conductcitation

    The concentrations of αSYN-F and Aβ-F used were selected based on previous studies.

    “The concentrations were selected based on our previous studies [11, 12, 23, 28, 29].”
    Quote in the paperNot a substantial claim4 of 5 sources checked
    • cites [11] Rostami J, Holmqvist S, Lindström V, Sigvardson J, Westermark GT, Ingelsson M, et al. Human astrocytes transfer aggregated alpha-synuclein via tunneling nanotubes. J Neurosci. 2017;37(49):11835–53. https://doi.org/10.1523/JNEUROSCI.0983-17.2017. source

      The Materials and Methods section says the 0.5 μM α-SYN exposure concentration was chosen based on previous investigations. It does not establish that the Aβ-F concentration was selected on that basis, so this source supports only the α-SYN part of the claim. (LLM, conf=0.87)

      Experimental — accuracy not yet measured
    • cites [12] Söllvander S, Nikitidou E, Brolin R, Söderberg L, Sehlin D, Lannfelt L, et al. Accumulation of amyloid-β by astrocytes result in enlarged endosomes and microvesicle-induced apoptosis of neurons. Molecular Neurodegeneration. 2016;11(1):38. https://doi.org/10.1186/s13024-016-0098-z. source
    • cites [23] Lindström V, Gustafsson G, Sanders LH, Howlett EH, Sigvardson J, Kasrayan A, et al. Extensive uptake of α-synuclein oligomers in astrocytes results in sustained intracellular deposits and mitochondrial damage. Mol Cell Neurosci. 2017;82:143–56. https://doi.org/10.1016/j.mcn.2017.04.009. source
    • cites [28] Beretta C, Nikitidou E, Streubel-Gallasch L, Ingelsson M, Sehlin D, Erlandsson A. Extracellular vesicles from amyloid-β exposed cell cultures induce severe dysfunction in cortical neurons. Sci Rep. 2020;10(1):19656. https://doi.org/10.1038/s41598-020-72355-2. source

      The Materials and methods sections report a 0.1 µM Aβ42 protofibril exposure and say the protofibrils were prepared using a previously established protocol (page not available in our copy). This supports a connection to prior Aβ work, but the paper does not say that the exposure concentration was selected on that basis and does not address αSYN-F concentrations. (LLM, conf=0.78)

      Experimental — accuracy not yet measured
    • cites [29] Nikitidou E, Khoonsari PE, Shevchenko G, Ingelsson M, Kultima K, Erlandsson A. Increased release of apolipoprotein E in extracellular vesicles following amyloid-β protofibril exposure of neuroglial co-cultures. J Alzheimers Dis. 2017;60(1):305–21. https://doi.org/10.3233/JAD-170278. source

      The Materials and Methods sections on synthetic Aβ42 protofibrils and Aβ42 protofibril exposure describe a previously established preparation protocol and report a 0.1 μM exposure concentration. They do not say that this concentration was selected based on previous studies, and the searched passages do not address selection of an αSYN-F concentration. (LLM, conf=0.72)

      Experimental — accuracy not yet measured
  • It may state two separate claims as one.

    Study design and conductcitation

    Human astrocytes used expressed the astrocytic markers vimentin, S100β, ALDH1L1 and GFAP, and human microglia expressed the microglial markers Iba1 and P2Y12.

    “Human astrocytes, expressing the astrocytic markers vimentin, S100β, ALDH1L1 and GFAP (Supplementary Figure 3 A), and human microglia, expressing the microglial markers Iba1 and P2Y12 (Supplementary Figure 3 B) were derived from the same hiPSC line [27].”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [27] McQuade A, Coburn M, Tu CH, Hasselmann J, Davtyan H, Blurton-Jones M. Development and validation of a simplified method to generate human microglia from pluripotent stem cells. Molecular Neurodegeneration. 2018;13(1):67. https://doi.org/10.1186/s13024-018-0297-x. source

      The Results section on engraftment (Fig. 5; page unavailable) reports that the derived human microglia express Iba1 and P2RY12. The paper does not report astrocytes expressing vimentin, S100β, ALDH1L1 and GFAP, or establish that the astrocytes and microglia in the citing study came from the same hiPSC line. The citing study points to its own supplementary figures for the marker observations. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim.

    Premisecitation

    Microglia and astrocytes coordinate their functions in many ways, both in the healthy and diseased brain.

    “However, recent data indicate that microglia and astrocytes coordinate their functions in many ways, both in the healthy and diseased brain [14–21].”
    Quote in the paperSubstantial claim7 of 8 sources checked
    • cites [14] Ali Khan MA, Yousef SA, Mullins CE. Percutaneous transluminal balloon pulmonary valvuloplasty for the relief of pulmonary valve stenosis with special reference to double-balloon technique. American Heart Journal. 1986;112(1):158–66. https://doi.org/10.1016/0002-8703(86)90695-2. source
    • cites [15] Gadani SP, Walsh JT, Smirnov I, Zheng J, Kipnis J. The glia-derived alarmin IL-33 orchestrates the immune response and promotes recovery following CNS injury. Neuron. 2015;85(4):703–9. https://doi.org/10.1016/j.neuron.2015.01.013. source

      The Introduction reports that IL-33 released after CNS injury acts on both astrocytes and microglia to induce chemokines, supporting an example of their coordinated response to injury. It reports IL-33 expression in the healthy brain, but not coordinated functions there, and does not establish that the two cell types coordinate in many ways. No page number is available in our copy. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
    • cites [16] Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541(7638):481–7. https://doi.org/10.1038/nature21029. source

      Section 2 shows one way microglia influence astrocytes: activated microglia secrete factors that induce A1 reactive astrocytes. The Introduction places this response in injury and disease. The paper does not establish that the two cell types coordinate their functions in many ways in the healthy brain; page numbers were not provided in our copy. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
    • cites [17] Shi Q, Chowdhury S, Ma R, Le KX, Hong S, Caldarone BJ, et al. Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice. Sci Transl Med. 2017;9(392):eaaf6295. https://doi.org/10.1126/scitranslmed.aaf6295. source

      The Discussion (page not provided) describes astrocyte-derived C3a acting on microglia in Alzheimer’s disease models, supporting an example of coordination in a diseased brain. It also says both cell types participate in synapse pruning, but does not establish that they coordinate their functions in many ways in both healthy and diseased brains. (LLM, conf=0.83)

      Experimental — accuracy not yet measured
    • cites [18] Rothhammer V, Borucki DM, Tjon EC, Takenaka MC, Chao C-C, Ardura-Fabregat A, et al. Microglial control of astrocytes in response to microbial metabolites. Nature. 2018;557(7707):724–8. https://doi.org/10.1038/s41586-018-0119-x. source

      The paper’s Abstract reports that microglial TGF-α and VEGF-B regulate astrocyte activity in an experimental model of multiple sclerosis, supporting coordination in a diseased CNS. It does not establish the broader claim that the cells coordinate their functions in many ways in both healthy and diseased brains. (LLM, conf=0.83)

      Experimental — accuracy not yet measured
    • cites [19] Batlle M, Ferri L, Andrade C, Ortega F-J, Vidal-Taboada JM, Pugliese M, et al. Astroglia-microglia cross talk during neurodegeneration in the rat hippocampus. Biomed Res Int. 2015;2015:102419. source

      The Introduction and Conclusions describe astrocyte–microglia interactions during neurodegeneration and brain injury, including astroglial influence on microglial responses. They do not establish coordination in the healthy brain, so that part of the cited sentence is not supported by this paper. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
    • cites [20] Lian H, Litvinchuk A, Chiang AC-A, Aithmitti N, Jankowsky JL, Zheng H. Astrocyte-microglia cross talk through complement activation modulates amyloid pathology in mouse models of Alzheimer’s disease. J Neurosci. 2016;36(2):577–89. https://doi.org/10.1523/JNEUROSCI.2117-15.2016. source

      The Introduction describes an astrocyte-to-microglia C3/C3aR pathway affecting amyloid dynamics and Alzheimer’s pathology, supporting coordination in a diseased brain. It does not establish that the cells coordinate their functions in many ways or show functional coordination in the healthy brain; the cited wild-type observations concern expression of C3 and C3aR. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
    • cites [21] Wu T, Dejanovic B, Gandham VD, Gogineni A, Edmonds R, Schauer S, et al. Complement C3 is activated in human AD brain and is required for neurodegeneration in mouse models of amyloidosis and tauopathy. Cell Rep. 2019;28:2111–2123.e6. source
  • It may state two separate claims as one.

    Premisecitation

    Stressed astrocytes respond by sending out tunneling nanotubes (TNTs), enabling intercellular transfer of pathogenic protein aggregates, as well as MHCII complexes to nearby cells.

    “Subsequently, stressed astrocytes respond by sending out tunneling nanotubes (TNTs), enabling intercellular transfer of pathogenic protein aggregates, as well as MHCII complexes to nearby cells [11, 24].”
    Quote in the paperSubstantial claim2 of 2 sources checked
    • cites [11] Rostami J, Holmqvist S, Lindström V, Sigvardson J, Westermark GT, Ingelsson M, et al. Human astrocytes transfer aggregated alpha-synuclein via tunneling nanotubes. J Neurosci. 2017;37(49):11835–53. https://doi.org/10.1523/JNEUROSCI.0983-17.2017. source

      The Discussion states that stressed astrocytes send out TNTs that transfer aggregated α-synuclein to healthy astrocytes. The cited paper does not report TNT-mediated transfer of MHCII complexes, so that part of the sentence is unsupported by this source. No page numbers are provided in our copy. (LLM, conf=0.90)

      Experimental — accuracy not yet measured
    • cites [24] Rostami J, Fotaki G, Sirois J, Mzezewa R, Bergström J, Essand M, et al. Astrocytes have the capacity to act as antigen-presenting cells in the Parkinson’s disease brain. Journal of Neuroinflammation. 2020;17(1):119. https://doi.org/10.1186/s12974-020-01776-7. source
  • It may state two separate claims as one.

    Premisecitation

    Astrocytes easily degrade αSYN and Aβ monomers, while they accumulate larger oligomers and fibrils.

    “These observations are in line with our previous discoveries that astrocytes easily degrade αSYN and Aβ monomers, while they accumulate larger oligomers and fibrils [11, 12].”
    Quote in the paperSubstantial claim2 of 2 sources checked
    • cites [11] Rostami J, Holmqvist S, Lindström V, Sigvardson J, Westermark GT, Ingelsson M, et al. Human astrocytes transfer aggregated alpha-synuclein via tunneling nanotubes. J Neurosci. 2017;37(49):11835–53. https://doi.org/10.1523/JNEUROSCI.0983-17.2017. source

      The Results section (page not provided) reports that human astrocytes rapidly degraded α-SYN monomers but retained α-SYN oligomers over six days. The Discussion also reports long-term storage of aggregated Aβ42. This paper does not establish degradation of Aβ monomers or accumulation of fibrils by astrocytes. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
    • cites [12] Söllvander S, Nikitidou E, Brolin R, Söderberg L, Sehlin D, Lannfelt L, et al. Accumulation of amyloid-β by astrocytes result in enlarged endosomes and microvesicle-induced apoptosis of neurons. Molecular Neurodegeneration. 2016;11(1):38. https://doi.org/10.1186/s13024-016-0098-z. source

      The Results section reports that astrocytes did not accumulate Aβ40 monomers but retained Aβ42 protofibrils, degrading them only slowly. The Discussion interprets this as a contrast between monomers and aggregated Aβ. This paper does not establish the same pattern for αSYN or for mature fibrils; those parts of the sentence are not supported by this source. (LLM, conf=0.87)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.

    Premisecitation

    Microglia and astrocytes are responsible for many inflammatory processes in affected brains, including phagocytosis of αSYN and Aβ aggregates, secretion of inflammatory mediators, and stimulation of the innate immune system.

    “Microglia and astrocytes are known to be responsible for many inflammatory processes in affected brains, including phagocytosis of αSYN and Aβ aggregates, secretion of inflammatory mediators, and stimulation of the innate immune system [8–12].”
    Quote in the paperNot a substantial claim4 of 5 sources checked
    • cites [8] Peri F, Nüsslein-Volhard C. Live imaging of neuronal degradation by microglia reveals a role for v0-ATPase a1 in phagosomal fusion in vivo. Cell. 2008;133(5):916–27. https://doi.org/10.1016/j.cell.2008.04.037. source

      The Introduction and the section on neuronal–microglial interactions during brain development describe microglia as CNS immune cells that phagocytose apoptotic neurons, primarily in developing zebrafish brains. They do not establish that microglia or astrocytes phagocytose αSYN or Aβ aggregates in affected brains, secrete inflammatory mediators, or stimulate the innate immune system. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
    • cites [9] Sofroniew MV. Multiple roles for astrocytes as effectors of cytokines and inflammatory mediators. The Neuroscientist: A Review Journal Bringing Neurobiology, Neurology and Psychiatry. 2014;20(2):160–72. https://doi.org/10.1177/1073858413504466. source
    • cites [10] Damisah EC, Hill RA, Rai A, Chen F, Rothlin CV, Ghosh S, et al. Astrocytes and microglia play orchestrated roles and respect phagocytic territories during neuronal corpse removal in vivo. Sci Adv. 2020;6:eaba3239. source

      The Introduction and Discussion report that microglia and astrocytes coordinate the phagocytic removal of dying neurons and their debris. They do not establish phagocytosis of αSYN or Aβ aggregates, secretion of inflammatory mediators, or stimulation of the innate immune system; the paper's findings concern neuronal corpse removal rather than that full list of inflammatory processes. (LLM, conf=0.87)

      Experimental — accuracy not yet measured
    • cites [11] Rostami J, Holmqvist S, Lindström V, Sigvardson J, Westermark GT, Ingelsson M, et al. Human astrocytes transfer aggregated alpha-synuclein via tunneling nanotubes. J Neurosci. 2017;37(49):11835–53. https://doi.org/10.1523/JNEUROSCI.0983-17.2017. source

      The Introduction reports that reactive astrocytes engulf Aβ and α-SYN aggregates and produce cytokines and chemokines. The paper does not establish the same activities for microglia or say that these cells stimulate the innate immune system; its Discussion instead mentions possible astrocyte involvement in T-cell activation. (LLM, conf=0.87)

      Experimental — accuracy not yet measured
    • cites [12] Söllvander S, Nikitidou E, Brolin R, Söderberg L, Sehlin D, Lannfelt L, et al. Accumulation of amyloid-β by astrocytes result in enlarged endosomes and microvesicle-induced apoptosis of neurons. Molecular Neurodegeneration. 2016;11(1):38. https://doi.org/10.1186/s13024-016-0098-z. source

      The Background (page not provided) says astrocytes engulf Aβ and α-synuclein aggregates, and that astrocytes and microglia secrete cytokines and neurotoxic products around Aβ plaques. It does not establish phagocytosis of both aggregates by microglia or state that these cells stimulate the innate immune system. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim. The paper’s conclusions may not depend on it.

    Premisecitation

    Astrocytes are capable of transferring αSYN as well as MHCII to other astrocytes via direct membrane contact and through TNTs.

    “Our previous results indicate that astrocytes are capable of transferring αSYN as well as MHCII to other astrocytes via direct membrane contact and through TNTs, implicating astrocytes as one of the important players in propagation of αSYN pathology [11, 24].”
    Quote in the paperNot a substantial claim2 of 2 sources checked
    • cites [11] Rostami J, Holmqvist S, Lindström V, Sigvardson J, Westermark GT, Ingelsson M, et al. Human astrocytes transfer aggregated alpha-synuclein via tunneling nanotubes. J Neurosci. 2017;37(49):11835–53. https://doi.org/10.1523/JNEUROSCI.0983-17.2017. source

      The Results section, “TNTs contribute to α-SYN transmission” (page unavailable), reports transfer of α-SYN between astrocytes through direct contact and TNTs. The cited paper does not report transfer of MHCII, so that part of the attributed claim is unsupported. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
    • cites [24] Rostami J, Fotaki G, Sirois J, Mzezewa R, Bergström J, Essand M, et al. Astrocytes have the capacity to act as antigen-presenting cells in the Parkinson’s disease brain. Journal of Neuroinflammation. 2020;17(1):119. https://doi.org/10.1186/s12974-020-01776-7. source

      The Results section on transfer between astrocytes (Fig. 6) and the Discussion report that MHC-II and αSYN/MHC-II complexes move between human astrocytes through tunneling nanotubes. The passages do not establish transfer of either αSYN or MHC-II through direct membrane contact as a separate route. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.

    Premisecitation

    Astrocytes and microglia degrade dead cells in a very organized and specialized manner; microglia degrade neuronal dendrites, cell bodies, and nuclei while astrocytes phagocytose apoptotic bodies that are released from dying neurons.

    “A recent study showed that astrocytes and microglia degrade dead cells in a very organized and specialized manner; microglia degrade neuronal dendrites, cell bodies, and nuclei while astrocytes phagocytose apoptotic bodies that are released from the dying neurons [10].”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [10] Damisah EC, Hill RA, Rai A, Chen F, Rothlin CV, Ghosh S, et al. Astrocytes and microglia play orchestrated roles and respect phagocytic territories during neuronal corpse removal in vivo. Sci Adv. 2020;6:eaba3239. source
  • Probably not a substantial claim. The paper’s conclusions may not depend on it.

    Premisecitation

    Incomplete degradation of Aβ42 protofibrils by astrocytes results in the release of extracellular vesicles containing N-truncated, neurotoxic Aβ.

    “We have previously shown that an incomplete degradation of Aβ42 protofibrils by astrocytes results in the release of extracellular vesicles containing N-truncated, neurotoxic Aβ [12].”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [12] Söllvander S, Nikitidou E, Brolin R, Söderberg L, Sehlin D, Lannfelt L, et al. Accumulation of amyloid-β by astrocytes result in enlarged endosomes and microvesicle-induced apoptosis of neurons. Molecular Neurodegeneration. 2016;11(1):38. https://doi.org/10.1186/s13024-016-0098-z. source
  • Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.

    Premisecitation

    Astrocytes are one of the major secretory cells in the CNS, responsible for secretion of neurotransmitters, growth factors, inflammatory mediators, and toxic proteins.

    “An accumulating body of evidence emphasizes astrocytes as one of the major secretory cells in the CNS, responsible for secretion of neurotransmitters, growth factors, inflammatory mediators, and toxic proteins [33].”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [33] Verkhratsky A, Matteoli M, Parpura V, Mothet J-P, Zorec R. Astrocytes as secretory cells of the central nervous system: idiosyncrasies of vesicular secretion. The EMBO journal. 2016;35(3):239–57. https://doi.org/10.15252/embj.201592705. source
  • It may state two separate claims as one.

    Premisecitation

    Astrocytes accumulate large amounts of αSYN and Aβ aggregates, resulting in severe cellular stress.

    “We have previously shown that astrocytes accumulate large amounts of αSYN and Aβ aggregates, resulting in severe cellular stress [11, 12, 23, 24].”
    Quote in the paperNot a substantial claim3 of 4 sources checked
    • cites [11] Rostami J, Holmqvist S, Lindström V, Sigvardson J, Westermark GT, Ingelsson M, et al. Human astrocytes transfer aggregated alpha-synuclein via tunneling nanotubes. J Neurosci. 2017;37(49):11835–53. https://doi.org/10.1523/JNEUROSCI.0983-17.2017. source

      The Discussion (page not provided) says that α-SYN accumulates in astrocytes and causes substantial cellular stress. It also reports that astrocytes engulf and store large amounts of aggregated Aβ42, but does not say that Aβ accumulation causes the stress described here. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
    • cites [12] Söllvander S, Nikitidou E, Brolin R, Söderberg L, Sehlin D, Lannfelt L, et al. Accumulation of amyloid-β by astrocytes result in enlarged endosomes and microvesicle-induced apoptosis of neurons. Molecular Neurodegeneration. 2016;11(1):38. https://doi.org/10.1186/s13024-016-0098-z. source
    • cites [23] Lindström V, Gustafsson G, Sanders LH, Howlett EH, Sigvardson J, Kasrayan A, et al. Extensive uptake of α-synuclein oligomers in astrocytes results in sustained intracellular deposits and mitochondrial damage. Mol Cell Neurosci. 2017;82:143–56. https://doi.org/10.1016/j.mcn.2017.04.009. source
    • cites [24] Rostami J, Fotaki G, Sirois J, Mzezewa R, Bergström J, Essand M, et al. Astrocytes have the capacity to act as antigen-presenting cells in the Parkinson’s disease brain. Journal of Neuroinflammation. 2020;17(1):119. https://doi.org/10.1186/s12974-020-01776-7. source

      The Background says αSYN accumulation in cultured human astrocytes causes severe cellular stress, and the section on intracellular αSYN deposits reports that these cells accumulated large amounts of aggregated αSYN. The passages do not establish the corresponding claim about Aβ aggregates or Aβ-induced stress. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
  • It may state two separate claims as one.

    Premisecitation

    Insufficient degradation of protein aggregates and chronic inflammation are driving forces of AD and PD brain pathology.

    “Growing evidence indicates that insufficient degradation of protein aggregates and chronic inflammation are driving forces of AD and PD brain pathology [30–32].”
    Quote in the paperSubstantial claim2 of 3 sources checked
    • cites [30] Nixon RA, Yang D-S, Lee J-H. Neurodegenerative lysosomal disorders: a continuum from development to late age. Autophagy. 2008;4(5):590–9. https://doi.org/10.4161/auto.6259. source

      The sections on pathological consequences in Alzheimer’s disease and lysosomal-system defects in Parkinson disease link impaired protein degradation to AD pathology and impaired α-synuclein degradation to familial PD. They do not support the additional claim that chronic inflammation drives pathology in either disease. (LLM, conf=0.87)

      Experimental — accuracy not yet measured
    • cites [31] Nixon RA. Autophagy, amyloidogenesis and Alzheimer disease. Journal of Cell Science. 2007;120(23):4081–91. https://doi.org/10.1242/jcs.019265. source
    • cites [32] Appelqvist H, Wäster P, Kågedal K, Öllinger K. The lysosome: from waste bag to potential therapeutic target. Journal of Molecular Cell Biology. 2013;5(4):214–26. https://doi.org/10.1093/jmcb/mjt022. source

      The Neurodegenerative disorders section links defective autophagy and lysosomal dysfunction to neurodegeneration and says brain inflammation is observed in Alzheimer’s and Parkinson’s diseases. The Future targeting section also links impaired lysosomal degradation to protein-accumulation diseases. But the paper describes inflammation as a secondary pathological change and hedges the role of lysosomal disturbance; it does not establish that chronic inflammation and insufficient aggregate degradation are both driving forces of AD and PD pathology. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
  • It may state two separate claims as one.

    Findingown data

    Astrocytes secrete a high proportion of their internalized protein aggregates, while microglia do not.

    “Analysis of conditioned medium and imaging data from the “close-culture” chamber experiments indicate that astrocytes secrete a high proportion of their internalized protein aggregates, while microglia do not.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: Cy3 labeling of αSYN and Aβ fibrils does not alter their uptake, accumulation, or degradation properties.
  • Probably not a substantial claim. The paper’s conclusions may not depend on it.

    Findingown data

    Exposure to aggregated αSYN or Aβ had very little effect on the cytokine profile.

    “Our data indicate that the exposure to aggregated αSYN or Aβ had very little effect on the cytokine profile.”
    Quote in the paperNot a substantial claim
  • It may state two separate claims as one.

    Findingown data

    Microglia continued to proliferate over the 7d, and the αSYN signal per cell was reduced over time, although the total αSYN content in the culture was unchanged.

    “Since microglia continued to proliferate over the 7d, the αSYN signal per cell was reduced over time, although the total αSYN content in the culture was unchanged (Fig. 1h–j and Supplementary Figure 2).”
    Quote in the paperNot a substantial claim
  • It may state two separate claims as one.

    Findingown data

    Intracellular αSYN increased over time in astrocytes, but remained unchanged in microglia cells.

    “Together with the finding that intracellular αSYN increased over time in astrocytes, but remained unchanged in microglia cells”
    Quote in the paperSubstantial claim
  • It may state two separate claims as one.

    Findingown data

    Following removal of αSYN, there was a clear reduction of intracellular deposits in the co-culture set-up at 24h+3d and 24h+6d, although some remaining deposits were not cleared.

    “In line with the results from the monocultures, there was a clear reduction of intracellular deposits in the co-culture set-up, following removal of αSYN (24h+3d and 24h+6d, Fig. 2i–k), although there were some remaining deposits that were not cleared.”
    Quote in the paperSubstantial claim
  • It may state two separate claims as one.

    Findingown data

    In microglia, the intracellular Aβ signal was significantly decreased at 4d, and no change in intracellular Aβ was observed from 4 to 7d.

    “In contrast to αSYN, the intracellular Aβ signal was significantly decreased at 4d. On the other hand, no change in intracellular Aβ was observed from 4 to 7d (Fig. 3h).”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim. The paper’s conclusions may not depend on it.

    Findingown data

    The intracellular levels of Aβ-F at 24h in astrocytes appeared lower than the levels of αSYN-F.

    “The intracellular levels of Aβ-F at 24h in astrocytes appeared lower than the levels of αSYN-F (Fig. 3c).”
    Quote in the paperNot a substantial claim
  • It may state two separate claims as one.

    Findingown data

    In separate cultures, both microglia and astrocytes ingest αSYN and Aβ aggregates, but microglia appear more effective in degrading the protein aggregates.

    “Our data show that in the separate cultures, both microglia and astrocytes ingest αSYN and Aβ aggregates, but microglia appear to be more effective in degrading the protein aggregates.”
    Quote in the paperSubstantial claim
  • It may state two separate claims as one.

    Findingown data

    Microglial cells are often found within ring-shaped areas, completely surrounded by astrocytic membrane, and anchored via sprouting extensions.

    “Often, the microglial cells were found within a ring-shaped area, completely surrounded by an astrocytic membrane.”
    • Also stated in: § Discussion · boosted
      “Moreover, microglia were often situated in ring-shaped areas, “in the middle” of astrocytes, clearly anchored to the astrocyte membrane via extending protrusions.”
    Quote in the paperNot a substantial claim
  • It may state two separate claims as one.

    Findingown data

    In the co-culture experiments, astrocytes also establish direct contact with microglia and the two glial cell types remained in a continual alliance for a long time.

    “In the co-culture experiments in this study, we found that astrocytes also establish direct contact with microglia and that the two glial cell types remained in a continual alliance for a long time, as shown by immunocytochemistry and time-lapse microscopy.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim. The paper’s conclusions may not depend on it.

    Findingown data

    No change in the intensity of CD68 staining was detected following αSYN or Aβ exposure.

    “No change in the intensity of the CD68 staining was detected following αSYN or Aβ exposure (Supplementary Fig 8).”
    Quote in the paperNot a substantial claim
  • It may state two separate claims as one.

    Findingown data

    The αSYN load in astrocytes is dramatically reduced during microglia interaction, with deposits appearing immediately degraded after transfer.

    “We also noted that the αSYN load in the astrocyte was dramatically reduced during the microglia interaction”
    • Also stated in: § Discussion · hedged
      “As shown with our time-lapse recordings, the αSYN-deposits appeared to be immediately degraded, after being transferred from astrocytes to microglia.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.

    Premisecitation

    In PD, intracellular inclusions of αSYN are found in neurons and glia, while both extracellular and intracellular deposits of Aβ are present in the AD brain.

    “In PD, intracellular inclusions of alpha-synuclein (αSYN) are found in neurons and glia, while both extracellular and intracellular deposits of amyloid-beta (Aβ) are present in the AD brain [2, 3].”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites [2] Goedert M. Parkinson’s disease and other alpha-synucleinopathies. Clin Chem Lab Med. 2001;39(4):308–12. https://doi.org/10.1515/CCLM.2001.047. source
    • cites [3] LaFerla FM, Green KN, Oddo S. Intracellular amyloid-beta in Alzheimer’s disease. Nat Rev Neurosci. 2007;8(7):499–509. https://doi.org/10.1038/nrn2168. source
  • It may state two separate claims as one.

    Interpretationown data

    Astrocyte and microglia interactions are important in Aβ/αSYN clearance, and glial cellular crosstalk is relevant in the progression of AD- and PD-related brain pathology.

    “Taken together, our data demonstrate the importance of astrocyte and microglia interactions in Aβ/αSYN clearance, highlighting the relevance of glial cellular crosstalk in the progression of AD- and PD-related brain pathology.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The hiPSC-derived astrocytes and microglia used in this study are representative of human brain astrocytes and microglia in AD and PD.
    • Rests on an assumption: A decrease in intracellular αSYN/Aβ signal over time reflects degradation of the ingested aggregates rather than secretion or other loss.
  • It may state two separate claims as one.

    Interpretationown data

    Some αSYN deposits are more difficult for astrocytes and microglia to clear, as intracellular αSYN was still observed in both monocultures at 24h+6d.

    “Notably, intracellular αSYN was still observed in both monocultures at 24h+6d, indicating that some deposits are more difficult for the cells to clear (Fig. 1e and i).”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: A decrease in intracellular αSYN/Aβ signal over time reflects degradation of the ingested aggregates rather than secretion or other loss.
  • Probably not a substantial claim. It may state two separate claims as one.

    Study design and conductown data

    The IntDen αSYN/Aβ signal was normalized to area rather than cell number because astrocytes and microglia proliferated during the experiment, and normalization to cell number would be misleading.

    “Since the astrocytes and microglia proliferated during the time course of the experiment (Supplementary Figure 1 and 2), we normalized the IntDen αSYN/Aβ signal to the area and not to the cell number. In proliferating cultures, normalization to the cell number is misleading as the deposits per cell will then be reduced without any degradation taking place.”
    Quote in the paperSubstantial claim
  • It may state two separate claims as one.

    Interpretationown data

    The presence of microglia either increases the degradation capacity of astrocytes or causes astrocytes to dispose of their inclusions via secretion or cell-to-cell transfer.

    “indicating that the presence of microglia either increases the degradation capacity of the astrocytes or causes astrocytes to dispose of their inclusions via secretion or cell-to-cell transfer.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim.

    Study design and conductreasoning

    Microglia were generated from the same human iPSC line as astrocytes to enable co-cultures without strain-induced immunological reactions.

    “To enable co-cultures of human iPSC-derived astrocytes and microglia without strain-induced immunological reactions, microglia were generated from the same human iPSC line that was used for deriving the NES cells.”
    Quote in the paperSubstantial claim
  • It may state two separate claims as one.

    Interpretationown data

    Although intracellular Aβ aggregates were significantly lowered in microglia at 24h+3d and 24h+6d, there were still some remaining Aβ deposits, indicating that microglia were not capable of complete degradation during the 6d time span.

    “Although the intracellular Aβ aggregates were significantly lowered at 24h+3d and 24h+6d, there were still some remaining Aβ deposits at these time points, indicating that the microglia were not capable of complete degradation during the 6d time span (Fig. 3i).”
    Quote in the paperSubstantial claim
    • Rests on an assumption: A decrease in intracellular αSYN/Aβ signal over time reflects degradation of the ingested aggregates rather than secretion or other loss.
  • It may state two separate claims as one.

    Interpretationcitation

    Microglia and astrocytes could share the burden by dividing toxic materials in a size-dependent manner, where microglia would phagocytose bigger aggregates and astrocytes smaller aggregates.

    “These data suggest that microglia and astrocytes could share the burden by dividing toxic materials in a size-dependent manner, where microglia would phagocytose bigger aggregates and astrocytes smaller aggregates.”
    Quote in the paperNot a substantial claim
  • It may state two separate claims as one.

    Interpretationown data

    Microglia attract and clear intracellular protein deposits directly from astrocytes.

    “indicating that microglia attract and clear intracellular protein deposits directly from the astrocytes (Fig. 9c).”
    Quote in the paperSubstantial claim
  • It may state two separate claims as one.

    Interpretationreasoning

    It is possible that astrocytes engulf less protein aggregates in the presence of microglia and thereby allow better degradation of the ingested material.

    “Hence, it is possible that astrocytes engulf less protein aggregates in the presence of microglia and thereby allow better degradation of the ingested material.”
    Quote in the paperSubstantial claim
  • It may state two separate claims as one.

    Interpretationown data

    αSYN-F/Aβ-F is cleared predominantly by lysosomal degradation and do not end up in other cellular compartments.

    “suggesting that the αSYN-F/Aβ-F is cleared predominantly by lysosomal degradation and do not end up in other cellular compartments.”
    Quote in the paperSubstantial claim
37 of 37
  • The paper relies on this without support.

    The hiPSC-derived astrocytes and microglia used in this study are representative of human brain astrocytes and microglia in AD and PD.

    “Human astrocytes were generated from neuroepithelial-like stem (NES) cells, produced from human-induced pluripotent stem cells (iPSCs, Cntrl9 cell line) [25, 26].”
  • The paper relies on this without support.

    Cy3 labeling of αSYN and Aβ fibrils does not alter their uptake, accumulation, or degradation properties.

    “The αSYN-F were Cy3-labelled using Cy3AM antibody labelling kit (GE Healthcare, PA33000) as described previously [24].”
  • The paper relies on this without support.

    A decrease in intracellular αSYN/Aβ signal over time reflects degradation of the ingested aggregates rather than secretion or other loss.

    “However, upon removal of extracellular αSYN-F, the intracellular αSYN signal decreased, indicating that the astrocytes were capable of degrading at least a proportion of the ingested αSYN-F (Fig. 1e).”
  • The paper relies on this without support.

    The cell markers used (Iba1, vimentin, S100B, etc.) specifically identify microglia and astrocytes in co-culture.

    “In both the separate cultures and in the co-cultures, microglia and astrocytes were outlined using the cellular markers Iba1 and vimentin, limiting the analysis to internalized αSYN/Aβ only.”
4 of 4

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Microglia can attach to cell membrane of astrocytes, attracting and clearing intracellular protein deposits such as α-synuclein and Aβ from astrocytes.

    “In addition, microglia can also attach to the cell membrane of astrocytes, attracting and clearing intracellular protein deposits, such as α-synuclein and Aβ, from the astrocytes.73”

    From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [73]

    The Results section on cell-to-cell transfer (Fig. 9; page unavailable) shows microglia attaching to astrocyte membranes as intracellular α-synuclein deposits shift toward them and decrease. The paper also reports reduced Aβ deposits in co-cultured astrocytes, but does not show that membrane-attached microglia attract and clear Aβ by the same mechanism. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • Image analysis is described as both excluding and using cell-number normalization

    Major

    The image-analysis methods say the aggregate signal was normalized to area, not cell number, including in co-cultures. The results instead describe normalizing the co-culture αSYN signal to the number of each cell type.

  • Astrocytic Aβ is called stable despite a reported increase at day 4

    Minor

    The Fig. 3 caption says astrocytic Aβ levels remain stable, but its description reports a significant increase at 4 days relative to 24 hours.

2 of 2

Citations

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Metadata

Authors
Rostami, J., Mothes, T., Kolahdouzan, M., Eriksson, O., Moslem, M., Bergström, J., Ingelsson, M., O’Callaghan, P., Healy, L. M., Falk, A., & Erlandsson, A.
Affiliations
  • Uppsala University (SE)
  • Montreal Neurological Institute and Hospital (CA)
  • Karolinska Institutet (SE)
Corresponding author
Erlandsson, Anna
Venue
Journal of Neuroinflammation
Published
2021-06-03
Volume
18
Issue
1
Pages
124-124
ISSN
1742-2094 (ISSN-L)
OpenAlex
W3116421092
Cited by
224
References
34
Citations by year
2026: 50 · 2025: 40 · 2024: 55 · 2023: 50 · 2022: 26 · 2021: 3
FWCI
11.03
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuroinflammation (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • TSpace (University of Toronto) (submittedVersion, cc-by)
  • PubMed Central (submittedVersion, cc-by)
  • KTH Publication Database DiVA (KTH Royal Institute of Technology) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Vetenskapsrådet (2018-02659)
  • Parkinsonfonden (1229/19)
  • Alzheimerfonden (AF-930515)
  • Hjärnfonden (FO2018-0153)
  • Åhlén-stiftelsen (193013)
  • Demensförbundet
  • Torsten Söderbergs Stiftelse (M60/18)
  • O. E. och Edla Johanssons Vetenskapliga Stiftelse
  • Stiftelsen Olle Engkvist Byggmästare (191-0410)
  • Stiftelsen Apotekare Hedbergs Fond för Medicinsk Forskning (991)
  • Gun och Bertil Stohnes Stiftelse
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Keywords
astrocyte-microglia crosstalk, alpha-synuclein, amyloid-beta, protein aggregate clearance, Alzheimer's disease, Parkinson's disease, glial interactions, tunneling nanotubes, co-culture, neuroinflammation
MeSH terms
Alzheimer Disease, Astrocytes, Brain, Cells, Cultured, Humans, Parkinson Disease, Amyloid beta-Peptides, Microglia, Microscopy, Confocal, Coculture Techniques, Cell Membrane Structures, Nanotubes, alpha-Synuclein, Induced Pluripotent Stem Cells, Proteolysis, Protein Aggregation, Pathological, Protein Aggregates

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-18, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-18 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review